Summit Therapeutics
SMMT
#1556
Rank
HK$110.23 B
Marketcap
HK$142.02
Share price
-3.46%
Change (1 day)
-26.05%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: HK$110.23 Billion

As of May 2026 Summit Therapeutics has a market cap of HK$110.23 Billion. This makes Summit Therapeutics the world's 1556th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$110.23 B4.91%
2025HK$105.07 B0.78%
2024HK$104.25 B629.77%
2023HK$14.28 B113.7%
2022HK$6.68 B226.17%
2021HK$2.04 B-31.62%
2020HK$2.99 B258.04%
2019HK$0.83 B464.97%
2018HK$0.14 B-88.53%
2017HK$1.29 B58.3%
2016HK$0.81 B-25.29%
2015HK$1.09 B

End of Day market cap according to different sources

On May 13th, 2026 the market cap of Summit Therapeutics was reported to be:

HK$114.18 Billion
by Nasdaq info icon info icon
HK$114.18 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
HK$15.44 B-85.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
HK$1.75 B-98.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
HK$1.96 B-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
HK$48.27 B-56.21%๐Ÿ‡บ๐Ÿ‡ธ USA